Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
AssigneeNestec S.A.
InventorsJalil Benyacoub, Stephanie Blum-Sperisen, Florence Rochat, Thierry Von der Weid
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of probiotic on expecting female mammals to boost the immune status of offspring. The use can induce an enhanced response of the offspring after birth to an infectious antigenic exposure. Ultimately the use of probiotic in expecting females can induce a better protection of offspring against infectious diseases.
Claims20
A method for improving immunity in an offspring, the method comprising:
- administering to a female mammal, for a time period that begins one to two months before fecundation and is more than 50% of the gestation period, a composition comprising an effective amount of a probiotic so as to boost the immunity of the offspring after birth;
- and
- administering an effective amount of the probiotic to the offspring after birth via the female mammal that is lactating, the probiotic comprising Bifidobacterium lactis CNCM I-3446.
A method for boosting the immunity of an offspring, the method comprising:
- administering to a female mammal, for a time period that begins one to two months before fecundation and is more than 50% of the gestation period, a composition comprising a probiotic that is Bifidobacterium lactis CNCM I-3446, the probiotic being present in an amount equivalent to between 103 and 1010 cfu per gram of dry composition.
A method for improving immunity to tetanus toxoid vaccination in an offspring, the method comprising:
- administering to a female mammal, for a time period that begins one to two months before fecundation and is more than 50% of the gestation period, a composition comprising an effective amount of a probiotic so as to boost the immunity to tetanus toxoid vaccination of the offspring after birth;
- and
- administering an effective amount of the probiotic to the offspring after birth via the lactating mother, the probiotic comprising Bifidobacterium lactis CNCM I-3446.
Dependencies are inferred from the claim text.